JAMA Network
About The Study: During 2012 to 2023, the prevalence of injecting methamphetamine only or both methamphetamine and opioids increased significantly among people who inject drugs entering treatment, including in areas where methamphetamine injection was previously rare (e.g., the Northeast). These findings build on prior work showing increases in opioid and methamphetamine co-use (regardless of route) among people who inject drugs before the COVID-19 pandemic.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
